[pending] GABAPENTIN (GABAPENTIN)
Pending LLM rewrite. Source: FDA_DRUG D-0508-2025.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
Defective container; blister packaging inadequately sealed.
The recalled product
- Product
- GABAPENTIN (GABAPENTIN)
- Brand
- GABAPENTIN
- Manufacturer
- The Harvard Drug Group LLC
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# M05205A and M05205B
- Exp Date 10/2026.
UPCs (2)
- 0055154336307
- 0055154799201
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · GABAPENTIN
- ModerateGabapentin Capsules 100 mg recalled for defective blister packaging
FDA (Drugs) · 2025-07-09
- ModerateGabapentin 600mg Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-16
- LowGabapentin Capsules 400 mg Recalled for Cross Contamination
FDA (Drugs) · 2025-04-16
- LowGabapentin Capsules Recalled for Cross Contamination
FDA (Drugs) · 2025-04-16
- HighGabapentin 600 mg Tablets Recalled Due to Metformin Contamination
FDA (Drugs) · 2024-08-14
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22